| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC0541 |
| Trial ID | NCT04689659 |
| Disease | T-Cell Lymphoblastic Leukemia |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Beijing Boren Hospital |
| Other ID(s) | BR-IIT-LCYJ-2020-005 |
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||